Q1 2026 Holdings
Filed 2026-05-15 | 35 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $445.7M | 9,066,621 | 29.5% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $174.0M | 673,505 | 11.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $135.6M | 4,164,120 | 9.0% |
| Immunome Inc(IMNM) | COM | 45257U108 | $121.6M | 5,558,885 | 8.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $119.9M | 7,732,808 | 7.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $80.6M | 14,549,768 | 5.3% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $58.0M | 15,470,502 | 3.8% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $36.6M | 4,368,804 | 2.4% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $35.6M | 5,539,724 | 2.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $29.5M | 1,237,659 | 2.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $29.4M | 1,459,599 | 1.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $26.5M | 688,036 | 1.8% |
| Absci Corporation(ABSI) | COM | 00091E109 | $24.8M | 8,253,316 | 1.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $17.4M | 521,117 | 1.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $16.0M | 7,964,188 | 1.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $15.4M | 12,872,946 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.3M | 262,674 | 1.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $14.5M | 2,011,895 | 1.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $13.5M | 3,153,256 | 0.9% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $12.3M | 491,654 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $11.4M | 2,164,777 | 0.8% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $10.3M | 491,340 | 0.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.8M | 173,859 | 0.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.3M | 261,508 | 0.5% |
| Ceribell Inc(CBLL) | COM | 15678C102 | $7.1M | 386,786 | 0.5% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $6.9M | 108,354 | 0.5% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $5.9M | 103,464 | 0.4% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $5.5M | 1,590,832 | 0.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $5.3M | 415,710 | 0.3% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $5.1M | 700,000 | 0.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $4.4M | 733,350 | 0.3% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $3.4M | 2,648,659 | 0.2% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $2.1M | 441,701 | 0.1% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $1.6M | 156,250 | 0.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $972.9K | 772,126 | 0.1% |